Teledyne Technologies Earnings Call Transcripts
Fiscal Year 2026
-
The company reported record Q2 results with strong organic growth, driven by defense, space, and semiconductor inspection markets. The Varex acquisition expands healthcare and industrial imaging, while disciplined M&A and product pruning continue. Margins improved despite mix headwinds and inflation.
-
Record Q2 results with sales up 9.8% and non-GAAP earnings up 20.8% year-over-year, driven by strong Digital Imaging and broad-based growth. 2026 outlook raised for revenue and EPS, with robust defense and commercial demand, ample capital for acquisitions, and continued margin expansion.
-
Record Q1 results with 7.6% sales and 17.2% non-GAAP EPS growth, led by Digital Imaging and Aerospace & Defense. Full-year guidance raised, with strong defense demand, robust backlog, and increased investment in R&D and capacity.
-
Defense and space remain key growth drivers, with unmanned systems and imaging platforms leading expansion. The company focuses on high-performance niches, methodical AI adoption, and disciplined capital deployment, while maintaining strong margins and a stable outlook across core segments.
Fiscal Year 2025
-
Q4 and full-year 2025 saw record sales, earnings, and margins, driven by strong defense and recovering commercial markets. 2026 guidance projects continued growth, with robust order backlog, healthy cash flow, and a focus on acquisitions and operational excellence.
-
Record Q3 sales, non-GAAP EPS, and free cash flow were achieved, with strong growth in defense and digital imaging segments. Full-year guidance was raised, and robust backlog and contract opportunities support a positive outlook despite minor risks from the U.S. shutdown and China.
-
Record quarterly sales and double-digit EPS growth were driven by strength in energy, defense, and unmanned systems, with robust order activity and improving margins in key segments. Management remains cautious on short-cycle demand due to trade policy uncertainty but raised full-year guidance.
-
Record Q1 sales and margins were achieved, with organic growth in all segments and strong order momentum. Guidance assumes a 1% GDP hit and tariff headwinds, but full-year EPS and margin improvement are maintained. Acquisitions and backlog growth support a positive outlook.
-
Long-cycle businesses like defense and marine are driving steady growth, while short-cycle segments are gradually recovering. Margin improvements continue, especially in imaging, and recent acquisitions are expected to be accretive despite short-term margin dilution. M&A remains the primary use of free cash flow.
Fiscal Year 2024
-
Record Q4 and full-year results with strong free cash flow and margin expansion. 2025 guidance calls for 4% sales growth (3.2% organic), 8% non-GAAP earnings growth, and over $1B free cash flow, with acquisitions contributing to top-line and EPS accretion.
-
Record Q3 sales and backlog driven by strong long-cycle business demand and FLIR performance. Margins held up despite short-cycle weakness, with robust cash flow and active capital allocation. Outlook remains positive but cautious due to global uncertainties.
-
Portfolio strength lies in long-cycle, backlog-driven businesses, while short-cycle segments are recovering from recent declines. Growth is expected to return as comps improve, with disciplined capital deployment through buybacks and bolt-on acquisitions.
-
Record free cash flow enabled significant capital deployment, with strong defense and marine instrumentation offsetting declines in industrial imaging. Sequential sales and earnings growth are expected to continue, supported by a record backlog and robust outlook for defense, energy, and aerospace.